A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : KRAS

Search Conditions:
Search Keyword : KRAS
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: KRAS
Appearance Frequency: 654 time(s)
Long forms: 21

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
Kirsten rat sarcoma viral oncogene homolog
(425 times)
Neoplasms
(220 times)
EGFR (173 times)
NSCLC (85 times)
CRC (64 times)
2006 Genotype-specific signal generation based on digestion of 3-way DNA junctions: application to KRAS variation detection.
Kirsten Ras
(80 times)
Neoplasms
(37 times)
CRC (17 times)
EGFR (16 times)
APC (6 times)
1990 Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation.
Kirsten rat sarcoma
(78 times)
Neoplasms
(36 times)
EGFR (23 times)
NSCLC (22 times)
ALK (8 times)
2009 Follow-up study of K-ras mutations in the plasma of patients with pancreatic cancer: correlation with clinical features and carbohydrate antigen 19-9.
KRAS proto-oncogene, GTPase
(25 times)
Neoplasms
(13 times)
TP53 (6 times)
BRAF (4 times)
CRC (3 times)
2016 Low mutation percentage of KRAS and BRAF genes in Brazilian anal tumors.
Kirsten ras oncogene
(10 times)
Neoplasms
(6 times)
EGFR (5 times)
CRC (3 times)
ALK (1 time)
1996 Transgenic mice carrying the human KRAS oncogene under the control of a thyroglobulin promoter: KRAS expression in thyroids analyzed by in situ hybridization.
Kirsten rat sarcoma virus
(8 times)
Neoplasms
(4 times)
EGFR (3 times)
AC (1 time)
AUC (1 time)
2012 High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.
KRAS proto-oncogene
(6 times)
Neoplasms
(3 times)
EGFR (2 times)
aHR (1 time)
APC (1 time)
2017 Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.
KRAS mt
(5 times)
Neoplasms
(2 times)
EGFR (2 times)
CCR7 (1 time)
DFS (1 time)
2011 Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer.
K-ras oncogene
(3 times)
Neoplasms
(2 times)
EGFR (2 times)
HADS (1 time)
mCRC (1 time)
2010 Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS.
10  Kirsten ras oncogene homolog gene
(2 times)
Neoplasms
(2 times)
EGFR (2 times)
EGFR-TKI (1 time)
EpCAM (1 time)
2008 Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications.
11  Kristen rat sarcoma
(2 times)
Neoplasms
(2 times)
ALK (1 time)
CP (1 time)
CRCs (1 time)
2014 Prevalence of KRAS mutations in metastatic colorectal cancer: A retrospective observational study from India.
12  Ki-Ras
(1 time)
Cell Biology
(1 time)
--- 2006 Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes.
13  kirsten human rat sarcoma protein
(1 time)
Neoplasms
(1 time)
ALK (1 time)
EGFR (1 time)
mTOR (1 time)
2018 Targeted therapies for advanced non-small cell lung cancer.
14  kirsten RAS viral oncogene homolog
(1 time)
Hematology
(1 time)
AML (1 time)
CDK1 (1 time)
mTOR (1 time)
2015 Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies.
15  Kirsten retrovirus-associated DNA sequences
(1 time)
Neoplasms
(1 time)
APC (1 time)
ARID1A (1 time)
ATM (1 time)
2019 Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome Sequencing.
16  Kirsten RSAS
(1 time)
Neoplasms
(1 time)
5-FU (1 time)
DCR (1 time)
LC (1 time)
2018 The impact of microsatellite instability status and sidedness of the primary tumor on the effect of bevacizumab-containing chemotherapy in patients with metastatic colorectal cancer.
17  Kirsten-rous avian sarcoma
(1 time)
Neoplasms
(1 time)
EGFR (1 time)
IGF-1 (1 time)
MET (1 time)
2012 Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC).
18  KRAS and NRAS were analyzed
(1 time)
Natural Science Disciplines
(1 time)
EGFR (1 time)
mCRC (1 time)
2019 KRAS and NRAS pyrosequencing screening in Tunisian colorectal cancer patients in 2015.
19  KRAS gene
(1 time)
Neoplasms
(1 time)
ACM (1 time)
CRC (1 time)
CSM (1 time)
2019 Statin uses and mortality in colorectal cancer patients: An updated systematic review and meta-analysis.
20  KRAS onc
(1 time)
Neoplasms
(1 time)
--- 2019 From basic researches to new achievements in therapeutic strategies of KRAS-driven cancers.
21  KRAS wildtype
(1 time)
Gastroenterology
(1 time)
BRAF (1 time)
CRC (1 time)
RR (1 time)
2017 Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes.